Evolus (EOLS) Intangibles (2017 - 2026)
Evolus (EOLS) posted Intangibles of $46.7 million for Q1 2026, down 2.7% on a QoQ basis from $48.0 million in Q4 2025, and down 5.3% year-over-year from $49.4 million in Q1 2025.
Evolus (EOLS) Intangibles (2017 - 2026) Analysis & Trends
Evolus' Intangibles history runs 10 years deep, the most recent figure standing at $46.7 million for Q1 2026.
- Quarterly Intangibles fell 5.3% year-over-year to $46.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.7 million (down 5.3% YoY) and the FY2025 annual result came in at $48.0 million, down 1.46% from the prior year.
- Intangibles was $46.7 million for Q1 2026 at Evolus, down from $48.0 million in the prior quarter.
- Across five years, Intangibles topped out at $50.0 million in Q1 2022 and bottomed at $46.3 million in Q2 2024.
- A 5-year average of $48.0 million and a median of $48.0 million in 2025 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles fell 6.6% — and 2025, when it climbed 6.64%.
- Evolus' Intangibles stood at $48.6 million in 2022, then fell by 3.06% to $47.1 million in 2023, then gained by 3.49% to $48.8 million in 2024, then decreased by 1.46% to $48.0 million in 2025, then dropped by 2.7% to $46.7 million in 2026.
- Business Quant data shows EOLS's Intangibles at $46.7 million in Q1 2026, $48.0 million in Q4 2025, and $48.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | 46.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.74 Mn |
| Dec 31, 2025 | 48.04 Mn |
| Sep 30, 2025 | 48.72 Mn |
| Jun 30, 2025 | 49.35 Mn |
| Mar 31, 2025 | 49.36 Mn |
| Dec 31, 2024 | 48.75 Mn |
| Sep 30, 2024 | 46.59 Mn |
| Jun 30, 2024 | 46.28 Mn |
| Mar 31, 2024 | 46.59 Mn |
| Dec 31, 2023 | 47.11 Mn |
| Sep 30, 2023 | 46.51 Mn |
| Jun 30, 2023 | 47.22 Mn |
| Mar 31, 2023 | 47.93 Mn |
| Dec 31, 2022 | 48.60 Mn |
| Sep 30, 2022 | 49.11 Mn |
| Jun 30, 2022 | 49.42 Mn |
| Mar 31, 2022 | 50.03 Mn |
| Dec 31, 2021 | 50.63 Mn |
| Sep 30, 2021 | 51.47 Mn |
| Jun 30, 2021 | 52.31 Mn |